Transcriptional control of the terminal fate of monoaminergic neurons

Author(s): Flames N, Hobert O

Abstract

Monoaminergic neurons are critical functional components of all nervous systems across phylogeny. The terminally differentiated state of individual types of monoaminergic neurons is defined by the coordinated expression of a battery of genes that instructs the synthesis and transport of specific monoamines, such as serotonin or dopamine. Dysfunction or deregulation of several of these enzymes and transporter system has been proposed to be the underlying basis of several pathological conditions. We review here the state of knowledge of the nature of the transcriptional regulatory programs that control the expression of what we term monoaminergic gene batteries (enzymes and transporters for specific monoamines) and thereby define the terminally differentiated state of monoaminergic neurons. We review several case studies in vertebrate and invertebrate model systems and propose that the coordinated expression of the genes that define individual monoaminergic cell types may be brought about by transcriptional coregulatory strategies.

Similar Articles

Etiology of Parkinson's disease: Genetics and environment revisited

Author(s): Steece-Collier K, Maries E, Kordower JH

Dopamine neuron agenesis in Nurr1-deficient mice

Author(s): Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, et al.

Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neuron

Author(s): Castillo SO, Baffi JS, Palkovits M, Goldstein DS, Kopin IJ, et al.

Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells

Author(s): Hermanson E, Joseph B, Castro D, Lindqvist E, Aarnisalo P, et al.

Transcription factor Nurr1 maintains fiber integrity and nuclearencoded mitochondrial gene expression in dopamine neurons

Author(s): Kadkhodaei B, Alvarsson A, Alvarsson A, Schintu N, Ramskold D, et al.

NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection

Author(s): Volakakis N, Kadkhodaei B, Joodmardi E, Wallis K, Panman L, et al.

A-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons

Author(s): Decressac M, Kadkhodaei B, Mattsson B, Laguna A, Perlmann T, et al.

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson’s disease

Author(s): Oh S, Chang M, Song J, Rhee Y, Joe E, et al.

Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease

Author(s): Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, et al.

Familial Parkinson's disease: a hint to elucidate the mechanisms of nigral degeneration

Author(s): Hattori N, Kobayashi H, Sasaki-Hatano Y, Sato K, Mizuno Y

Mutations in NR4A2 associated with familial Parkinson disease

Author(s): Le WD, Xu P, Jankovic J, Jiang H, Appel SH, et al.

Translated mutation in the Nurr1 gene as a cause for Parkinson's disease

Author(s): Grimes DA, Han F, Panisset M, Racacho L, Xiao F, et al.

Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra

Author(s): Chu Y, Kompoliti K, Cochran EJ, Mufson EJ, Kordower JH

NURR1 mutations in cases of schizophrenia and manic-depressive disorder

Author(s): BuervenichS, Carmine A, Arvidsson M, Xiang F, ZhangZ, et al.

Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism

Author(s): Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ

Regulation of GTP cyclohydrolase I expression by orphan receptor Nurr1 in cell culture and in vivo

Author(s): Gil M, McKinney C, Lee MK, Eells JB, Phyillaier MA, et al.

Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons

Author(s): Kadkhodaei B, Ito T, Joodmardi E,Mattsson B, Rouillard C, et al.

Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice

Author(s): Imam SZ, Jankovic J, Ali SF, Skinner JT, Xie W, et al.

Aging of the striatum: mechanisms and interventions

Author(s): Umegaki H, Roth GS, Ingram DK

Structure and function of the Nur77 subfamily, a unique class of hormone nuclear receptors

Author(s): Eells JB,Witta J,Otridge JB, Zuffova E, Nikodem VM

Age-dependent dopaminergic dysfunction in Nurr1 knockout mice

Author(s): Iang C, Wan X, He Y, Pan T, Jankovic J, et al.

Chronic Toxoplasma gondii in Nurr1-null heterozygous mice exacerbates elevated

Author(s): EellJB, Varela-Stokes A, Guo-Ross SX, Kummari E, Smith HM, et al.

Parkinson disease in twins: an etiologic study

Author(s): Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, et al.

No evidence for heritability of Parkinson disease in Swedish twins

Author(s): Wirdefeldt K, Gatz M, Schalling M, Pedersen NL

Heritability of Parkinson disease in Swedish twins: a longitudinal study

Author(s): Wirdefeldt K, Gatz M, Reynolds CA, Prescott CA, Pedersen NL

Decreased ethanol preferences and wheel running in Nurr1-deficient mice

Author(s): Werme M, HermansonE, Carmine A, Buervenich S, Zetterstrom RH, et al.

Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency

Author(s): VuillermotS, JoodmardiE, Perlmann T, Ove Ögren S,FeldonJ, et al.

Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain

Author(s): DiSalvio M, Di Giovannantonio LG, OmodeiD, AcamporaD, SimeoneA